APA (7th ed.) Citation

RT, K., A, B., E, F., V, D. P., S, G., DA, P., . . . PJ, H. (2019). Evaluation of entinostat alone and in combination with standard-of-care cytotoxic agents against rhabdomyosarcoma xenograft models. Pediatric blood & cancer, 66(8), e27820. https://doi.org/10.1002/pbc.27820

Chicago Style (17th ed.) Citation

RT, Kurmasheva, et al. "Evaluation of Entinostat Alone and in Combination with Standard-of-care Cytotoxic Agents Against Rhabdomyosarcoma Xenograft Models." Pediatric Blood & Cancer 66, no. 8 (2019): e27820. https://doi.org/10.1002/pbc.27820.

MLA (9th ed.) Citation

RT, Kurmasheva, et al. "Evaluation of Entinostat Alone and in Combination with Standard-of-care Cytotoxic Agents Against Rhabdomyosarcoma Xenograft Models." Pediatric Blood & Cancer, vol. 66, no. 8, 2019, p. e27820, https://doi.org/10.1002/pbc.27820.